This chapter explores the Supreme Court's decision to maintain unrestricted access to the Mifepristone abortion pill, challenging FDA restrictions that mandated in-person visits. The episode debates the FDA's boundaries in enforcing regulations and the implications of their actions.
The Supreme Court preserved full access to a widely used abortion pill in a case that carried major stakes for reproductive rights and election-year politics. Bloomberg's Paul Sweeney and Alix Steel bring you instant reaction from our Bloomberg News team.
See omnystudio.com/listener for privacy information.